Iris Lee

Staff Reporter (Health Care, Law)

Email: ilee@sfvbj.com
Phone: 818-316-3126 Extension: 124

Recent Stories

FDA Accepts Amgen's Aimovig Application

Amgen Inc. on Thursday announced that the U.S. Food and Drug Administration has accepted the biologics license application for Aimovig, a drug for prevention of migraine.

Expanding FloQast Creates Exec Position

FloQast Inc. on Tuesday announced the appointment of Rob Feinstein as vice president of product.

Amgen Collaboration on Cancer Drugs

Amgen Inc. on Tuesday announced a collaboration agreement with Array BioPharma for development of drugs for autoimmune disorders.

MannKind Names CFO

MannKind Corp. on Monday announced that Steven Binder has joined the company as chief financial officer.

FDA Approves Amgen Leukemia Drug

Amgen Inc.’s leukemia drug Blincyto has received full approval from the U.S. Food and Drug Administration, the company has announced.

MannKind Selects Chief Commercial Officer

MannKind Corp. on Wednesday announced that Patrick McCauley will join the company as chief commercial officer.

Cure, Israelis Partner on Pot Research

Cure Pharmaceuticals on Tuesday announced that it has signed a memorandum to enter into a research collaboration with two Israeli companies.

Revenue, Income Rise at Simulations Plus

Simulation Plus Inc. on Monday reported fiscal third-quarter earnings that showed rising revenue and net income.

Career Preppies

EDUCATION: Seventh-graders take first step to health jobs.

Feeling it’s never too early to start preparing for a career, Palmdale Prepatory Academy debuts focusing seventh graders on health care.

Disney at Center of Rumored Takeover Talks

ACQUISITION: Verizon latest suitor linked to Burbank media conglomerate.

Rumors of takeover boosts Disney’s stock price.

More stories >>